Monument Biosciences
Founded 2022 · 12 employees on LinkedIn · 2 known investors
Monument Biosciences is a biotechnology company developing disease-modifying drugs for Alzheimer's Disease and Related Dementias (ADRD). It explores diverse therapeutic modalities and combination therapies targeting neurodegeneration for patients and their families.
Investors · 2
Frequently asked questions
- What does Monument Biosciences do?
- Monument Biosciences is a biotechnology company developing disease-modifying drugs for Alzheimer's Disease and Related Dementias (ADRD). It explores diverse therapeutic modalities and combination therapies targeting neurodegeneration for patients and their families.
- Who are Monument Biosciences's investors?
- Monument Biosciences's investors include Elevate Ventures, Dolby Family Ventures.